OTLK
#3705
Outlook Therapeutics, Inc. - Common Stock
0.6 6 USD
0.00%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
0.00%
Monthly Change
-14.29%
6 month change
+54.10%
Year Change
+60.00%
Previous Close
0.6 6
Open
0.6 6
Low
0.6 6
High
0.6 6
Volume
14
Financials
- Market Capitalization 160.68 M
- Employee 17
- Founded 2010
- CEO N/A
- Website www.outlooktherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG00469JRJ5
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-1.53
Price to sales ratio
-96.61
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3703 |  ADAG Adagene Inc - ADS, each representing 1.25 | 3.40 USD | +2.72% | -4.23% | -13.04% | +51.79% | 161.11 M USD | ||
| 3704 |  CDXS Codexis, Inc. - Common Stock | 1.47 USD | +2.08% | 0.00% | -8.70% | -39.75% | 160.97 M USD | ||
| 3713 |  HUMA Humacyte, Inc. - Common Stock | 0.57 USD | 0.00% | -6.56% | -10.94% | -61.49% | 158.34 M USD | ||
| 3720 |  CRBP Corbus Pharmaceuticals Holdings, Inc. - Common Stock | 8.12 USD | -1.46% | -26.05% | -20.47% | -51.08% | 157.05 M USD |
Frequently asked questions about Outlook Therapeutics, Inc. Common Stock
What is the Outlook Therapeutics, Inc. Common Stock stock price today?
The current price of Outlook Therapeutics, Inc. Common Stock (OTLK) is 0.66. Over the past 24 hours, the stock has changed by 0.00%. Follow the OTLK chart for real-time price dynamics.
What is the stock ticker of Outlook Therapeutics, Inc. Common Stock?
Outlook Therapeutics, Inc. Common Stock trades under the ticker OTLK. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Outlook Therapeutics, Inc. Common Stock stock going up?
OTLK has changed by 0.00% over the last week, -14.29% over the last month, and +60.00% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Outlook Therapeutics, Inc. Common Stock?
Outlook Therapeutics, Inc. Common Stock currently has a market capitalization of 160.68 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Outlook Therapeutics, Inc. Common Stock earnings last quarter?
Last quarter, Outlook Therapeutics, Inc. Common Stock reported earnings of -0.15 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Outlook Therapeutics, Inc. Common Stock revenue for the last quarter?
Outlook Therapeutics, Inc. Common Stock reported quarterly revenue of -1.33 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Outlook Therapeutics, Inc. Common Stock net income for the last quarter?
Outlook Therapeutics, Inc. Common Stock reported net income of -20.32 M for the last quarter. The previous quarter showed -4.45 M, which means net income changed by -356.30%.
How many employees does Outlook Therapeutics, Inc. Common Stock have?
As of the latest available data, Outlook Therapeutics, Inc. Common Stock has 17 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Outlook Therapeutics, Inc. Common Stock stock?
You can buy Outlook Therapeutics, Inc. Common Stock (OTLK) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Outlook Therapeutics, Inc. Common Stock stock?
Investing in Outlook Therapeutics, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the OTLK chart and related analysis on metatrader.com as part of your research.